Abbrea Capital’s Cigna CI Stock Holding History

Abbrea Capital’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$349K	Buy	1,055 +125	+13%	+$43.1K	0.05%	184
2024 Q1	$338K	Hold	930	–	–	0.04%	199
2023 Q4	$278K	Hold	930	–	–	0.04%	204
2023 Q3	$266K	Hold	930	–	–	0.04%	204
2023 Q2	$261K	Hold	930	–	–	0.04%	209
2023 Q1	$238K	Sell	930 -141	-13%	-$41.1K	0.04%	213
2022 Q4	$355K	Hold	1,071	–	–	0.06%	176
2022 Q3	$297K	Sell	1,071 -14	-1%	-$3.94K	0.06%	181
2022 Q2	$286K	Hold	1,085	–	–	0.05%	193
2022 Q1	$260K	Hold	1,085	–	–	0.04%	220
2021 Q4	$249K	Buy	1,085 +84	+8%	+$17.9K	0.03%	227
2021 Q3	$200K	Sell	1,001 -28	-3%	-$6.09K	0.03%	245
2021 Q2	$244K	Hold	1,029	–	–	0.04%	220
2021 Q1	$249K	Buy	1,029 +36	+4%	+$8.02K	0.04%	208
2020 Q4	$207K	Buy	+993	New	+$195K	0.04%	210
2020 Q1	–	Sell	-1,071	Closed	-$219K	–	176
2019 Q4	$219K	Buy	+1,071	New	+$196K	0.05%	182
2019 Q1	–	Sell	-1,296	Closed	-$246K	–	169
2018 Q4	$246K	Buy	+1,296	New	+$270K	0.08%	151

Other funds holding CI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Abbrea Capital's CI Position: Q2 2024 in Review

Abbrea Capital increased its Cigna (CI) stake by 13% in Q2 2024, buying an estimated $43.1K and bringing the position to 1,055 shares worth $349K. The position accounts for 0.05% of the portfolio, ranked #184.

Abbrea Capital first reported a position in CI in Q4 2018 and has held it in 17 quarters since. The position peaked at $355K in Q4 2022. 1,666 funds tracked by Wall St. Rank hold CI as of Q2 2024.

Abbrea Capital held 1,055 shares of Cigna worth $349K as of Q2 2024.
Abbrea Capital bought 125 Cigna shares in Q2 2024, an estimated $43.1K.
Cigna made up 0.05% of Abbrea Capital's portfolio in Q2 2024, its #184 holding.
Abbrea Capital first reported a position in Cigna in Q4 2018 and has held it in 17 quarters since.
Abbrea Capital's Cigna position peaked at $355K in Q4 2022.
1,666 funds tracked by Wall St. Rank held Cigna as of Q2 2024.

Based on Abbrea Capital's 13F filing for Q2 2024, filed 8 Aug 2024.